Cargando…
Mechanism of azithromycin in airway diseases
Azithromycin (AZM) has been used to treat chronic inflammatory airway diseases because it regulates cell–cell contact between airway epithelial cells. Airway mucus hypersecretion is an important component of chronic respiratory diseases. Mucin 5AC (MUC5AC) is the major mucin produced by airway epith...
Autor principal: | Yang, Jie |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7323306/ https://www.ncbi.nlm.nih.gov/pubmed/32589092 http://dx.doi.org/10.1177/0300060520932104 |
Ejemplares similares
-
The impact of azithromycin therapy on the airway microbiota in asthma
por: Slater, Mariel, et al.
Publicado: (2014) -
The differential effects of azithromycin on the airway epithelium in vitro and in vivo
por: Slater, Mariel, et al.
Publicado: (2016) -
Azithromycin Inhibits Mucus Hypersecretion from Airway Epithelial Cells
por: Shimizu, Takeshi, et al.
Publicado: (2012) -
Azithromycin induces epidermal differentiation and multivesicular bodies in airway epithelia
por: Arason, Ari Jon, et al.
Publicado: (2019) -
Azithromycin during Wheezing Illnesses among Preschool Children: Does the Airway Microbiota Provide Insights into Mechanism?
por: Bacharier, Leonard B.
Publicado: (2021)